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Combined aptamer and 
transcriptome sequencing of single 
cells
Cyrille L. Delley  1, Leqian Liu1, Maen F. Sarhan1 & Adam R. Abate1,2,3
The transcriptome and proteome encode distinct information that is important for characterizing 
heterogeneous biological systems. We demonstrate a method to simultaneously characterize the 
transcriptomes and proteomes of single cells at high throughput using aptamer probes and droplet-
based single cell sequencing. With our method, we differentiate distinct cell types based on aptamer 
surface binding and gene expression patterns. Aptamers provide advantages over antibodies for single 
cell protein characterization, including rapid, in vitro, and high-purity generation via SELEX, and the 
ability to amplify and detect them with PCR and sequencing.
Cellular differentiation restricts the genetic programs that cells may execute, endowing distinct functions and 
phenotypes1,2. This enables important abilities, like the generation of tissues and organs; however, dysregula-
tion of this system can lead to diseases, like cancer3. On the microscopic level, important biological structures 
comprise heterogeneous ensembles of cells working in coordination4–7. The immune system, for example, uses 
multiple cell types to elicit a response to exogenous threats, prevent autoimmunity, and establish long-term mem-
ory8. In cancer, heterogeneity occurs in advanced malignancies and imposes a significant barrier to cure by often 
ensuring that a fraction of cancer cells resist treatment9–11. For heterogeneous systems, mixed, multicell measure-
ments do not allow resolution of different cells into their functional groups. High throughput single cell transcrip-
tome sequencing12–14 is an effective tool for deconvoluting heterogeneity because it provides ample information 
to identify cell type15 and infer cell state and function16. Moreover, it leverages the capacity of modern sequencing 
to analyze tens-of-thousands of cells per experiment, allowing analysis of populations17–19. Nevertheless, gene 
expression is dynamic and can change due to biologically important or trivial events, making data interpretation 
challenging. Indeed, there is often poor correlation between transcript count and protein abundance, particularly 
when measured in single cells20,21.
As the extreme boundary of cells, the membrane carries a molecular fingerprint useful for identifying cell 
type and function. This information is often complementary to gene expression data, being encoded in the pro-
teome and, thus, containing features not otherwise observable, like post-translational protein modifications. 
Consequently, for cell type discrimination, surface profiling with antibodies and fluorescence-activated cell sort-
ing (FACS) is the gold standard to classify cells into their myriad types via well-characterized biomarkers22,23. 
However, the approach requires that each antibody be labeled with a unique fluorophore, limiting multiplexing to 
tens of antibodies. By swapping fluorophores with mass tags and using a mass spectrometer for the readout, over a 
hundred antibodies can be used24,25, although this is still far short of the tens-of-thousands of genes, splice-forms, 
and post-translational modifications actively used by organisms and available for characterization by antibodies. 
Abseq replaces the mass tags with nucleic acid sequence tags, using droplet-based single cell sequencing for the 
readout26. Because a sequence tag is encoded by its full nucleobase set, an astronomical number of sequence 
combinations are available for unique antibody labeling, shattering the multiplexing barrier. Moreover, the micro-
fluidic approaches used to sequence single cell mRNA can be applied to the tags, allowing simultaneous surface 
and transcriptome profiling of single cells at high throughput27,28. While this provides exciting opportunities 
for characterizing cells with paired gene expression and protein data, it requires access to high-affinity antibod-
ies. Effective antibodies are available for common targets, but uncommon ones require custom generation, an 
involved process necessitating antigen purification29,30. Antigen purification can be costly and labor intensive, 
and may not be possible depending on the native structure of the antigen31,32. Once obtained, the antibodies 
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must be conjugated to sequence tags, an additional step that can impact affinity. To enable simple and effective 
single cell surface profiling, an optimal approach would obviate the need for custom antibody generation and tag 
conjugation.
Here, we present Apt-seq, an approach to simultaneously profile the surfaces and transcriptomes of single cells 
using aptamers and single cell sequencing. Like antibodies, aptamers are affinity probes capable of specific bind-
ing to target epitopes33–36, and aptamer binding can be multiplexed. Unlike antibodies, aptamers are nucleic acids 
in which the nucleobase sequence provides an intrinsic tag that can be read out via DNA sequencing, obviating 
the need for additional tag conjugation. Moreover, specific, high-affinity aptamers can be readily and inexpen-
sively obtained with in vitro systematic evolution of ligands by exponential enrichment (SELEX)34,36,37. SELEX 
can be applied directly to living cells, avoiding antigen purification, and shortening the process from months to 
weeks38–40. This simplifies affinity reagent generation and enables new surface characterization only accessible 
to aptamers41. We demonstrate Apt-seq by using it to discriminate between cells based on aptamer binding and 
differences in gene expression.
Results
Aptamers allow single cell surface profiling via droplet barcoding and sequencing. Aptamers 
are nucleic acids that adopt a three-dimensional fold and bind specifically to protein epitopes and small mole-
cules34,36. Like antibodies, they can be used in combination for multiplexed characterization42, while being easily 
identified via nucleic acid sequencing. To allow simultaneous sequencing of cell mRNA and aptamers, we pol-
yadenylate the aptamers to mimic the structure of mRNA; this allows both to be captured and sequenced using 
identical poly-thymine primers (Fig. 1a). To label the cells with aptamers, the mixed aptamer library is incubated 
with a cell suspension, and unbound aptamers washed away (Fig. 1b). To barcode the cells, we employ Drop-seq, 
a high throughput microfluidic approach13, although other barcoding methods can also be used12,43–45. In Drop-
seq, cells are isolated in droplets with barcoded beads and lysis buffer (Fig. 1c)13. Upon lysis, aptamers and mRNA 
hybridize to poly-thymine barcode sequences on the beads (Fig. 1d), followed by demulsification, washing, and 
nucleic acid amplification12,46–48. Amplification conjugates a unique barcode sequence to all aptamers and tran-
scripts of a single cell, allowing material for many cells to be pooled, sequenced, and computationally deconvo-
luted by barcode. This provides, for every cell, paired aptamer and transcript reads (Fig. 1e) that are separated in 
silico (Fig. 1f,g).
Figure 1. Principle of the Apt-seq workflow. (a) A heterogeneous cell sample is incubated with a diverse 
aptamer library containing a poly-A sequence on its 3′-end. (b) Cells expressing epitopes of interest are 
decorated by the corresponding aptamers in the library and non-binding aptamers are washed away. (c) 
Single cells of the washed cell suspension are co-encapsulated with beads carrying a unique DNA barcode in a 
microfluidic device. (d) Each droplet contains lysis solution to lyse cells. Aptamers and mRNA molecules can 
hybridize with the barcoding beads by means of their poly-A sequence. Using the barcode bead as a primer 
in reverse transcription and DNA polymerase reactions, the droplet-specific unique barcode is fused to the 
mRNA and aptamer, providing a cell specific identifier. (e) Pooling all beads after barcode fusion, sequencing 
their content in parallel, and deconvoluting aptamers and mRNAs, allows evaluation of epitope profiles in single 
cells (f). (g) Since the cell-specific barcode is shared between aptamers and transcripts, the epitope data can be 
combined with the single cell transcriptome for further interdependent analysis.
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Polyadenylation does not impair aptamer function. For Apt-seq to be effective, the poly-adenylation 
required for paired transcriptome sequencing must not perturb aptamer binding49. To confirm this, we construct 
a library of five aptamers, TC01, TD05, TD08, TD09, and TE02, reported to bind Ramos cells with Kd from 
0.8 nM to 74.7 nM50. We also include TE17, sgc3b, and sgc8a aptamers that do not bind Ramos cells42,50,51. TD05, 
sgc3b, and sgc8a have reported protein targets, the membrane bound IgM, L-selectin, and PKT7, respectively52–54. 
To assess the impact of the poly-A tail on aptamer fold, we use RNAstructure55, a secondary structure prediction 
algorithm, and predict the same fold for the aptamers with and without poly-A tail (Fig. 2a). To assess whether 
the tails interfere with binding, we synthesize all eight polyadenylated aptamers and apply them to Ramos and 
control 3T3 cells. The aptamers are incubated at equal molar concentration with either cell line, followed by five 
wash cycles and concentration estimation in the final wash supernatant and final cell suspension by qPCR. In 
agreement with previous studies, TD05, TD08, and TE02 are highly enriched in Ramos cell suspensions, while 
TD09 is moderately enriched. In contrast, TC01, TE17, and sgc8a are not enriched in Ramos cells, as expected 
(Fig. 2b) (Supplementary Fig. 1). Sgc3b remains below the detection limit for either cell line. Notably, although 
sgc8a is a reported binder of human T-cells42, it enriches in mouse 3T3 cells. However, a previous study showed 
that both sgc8 and a PKT7 binding antibody can interact with other cell lines presumably devoid of PKT756. We 
conclude that poly-adenylating the aptamers does not affect fold or binding and that all except TC01 perform as 
previously reported in our hands.
Apt-seq provides independent information from RNAseq for inferring cell type. Inferring cell 
type from RNAseq data can be challenging due to the dynamic, complex, and multidimensional nature of gene 
expression. An advantage of Apt-seq is that it allows independent confirmation of cell type by aptamer binding. 
This can be used to support inferences from transcriptome data, or provide additional information for differen-
tiating between related cells and states. To illustrate these benefits, we perform combined aptamer and transcrip-
tome sequencing of suspended Ramos and 3T3 cells. After incubation and washing of the aptamers, we barcode 
the cells with Drop-seq. Drop-seq uses template switching to generate defined 3′-ends on cDNA, enabling subse-
quent PCR amplification. After amplification, cDNA is tagmented to generate ~500 bp fragments containing nec-
essary sequencing handles. Aptamers lack the 5′-cap of mRNA and, thus, template switching is non-processive, 
preventing addition of the handles by this route. However, our aptamers are constructed with known flanking 
sequences, which we use for amplification and handle attachment. Additionally, the aptamers are short (below 
200 bp), so that amplicons can be sequenced without tagmentation (Methods, Supplementary Tables 1 and 2). 
These simplifications allow efficient, joint processing of aptamers and mRNA in the same barcoding reaction.
After barcoding, the nucleic acids of many cells are pooled and sequenced. We aim for about 200 cells and 
perform limited Illumina MiSeq sequencing collecting ~12 million paired-end reads. We computationally group 
reads to single cells using barcodes, and then to single molecules using unique molecular identifiers (UMIs). After 
processing, we obtain high-quality transcriptome and aptamer data for 58 cells, with >4500 unique reads per cell. 
More cells can be obtained by sequencing deeper and collecting more beads13. As expected, most reads belong to 
the transcriptome, and a smaller fraction to surface-bound aptamers (Fig. 3a). The aptamer profiles segregate into 
two groups, with TD08 and TE02, and to a lesser degree TD05 and TD09. The aptamer sgc8a is predominantly 
anticorrelated with this group. We obtain few reads for TC01, TE17, and sgc3b (Fig. 3b), consistent with our 
multicell qPCR results (Fig. 2b). Based on the qPCR results and because TD05 is a binder of the immunoglobulin 
heavy chain, we expect the first rectangular block to represent Ramos and the second 3T3 cells. Because these cells 
are from different species, cell type can be inferred by direct sequence analysis of cDNA. To verify our aptamer 
results, we thus evaluate the transcript reads of each cell. We order the transcriptome data using the same y-axis as 
the aptamers and again observe a clear block segregation, indicating that the gene expression of the two cell types 
is differentiated as expected. Based on transcript sequences, we confirm that the lower block corresponds to the 
human Ramos and the upper block to the mouse 3T3 cells (Fig. 3c).
Figure 2. Influence of the 3′-poly-A tail on aptamer structure and function. (a) Predicted secondary structure 
of the aptamers TD05 and TD09 with and without poly-A tail. (b) The functionality of the aptamers TC01, 
TD05, TD08, TD09, TE02, TE17 and sgc8a, all modified with a 3′-poly-A tail is evaluated based on their ability 
to bind to Ramos or 3T3 cells. The concentration of the aptamers is estimated in the supernatant and cellular 
fraction after five wash cycles by qPCR. Each bar represents the mean of a technical triplicate and uncertainty is 
given as one sample standard deviation.
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To confirm the relationship between expected aptamer and gene expression data, we construct a barnyard 
plot, displaying each cell as a 2D coordinate corresponding to the number of human and mouse transcripts iden-
tified within its barcode cluster (Fig. 3d). We extract the principal components of the aptamer read per cell matrix 
by calculating a singular value decomposition (SVD) (Fig. 3d, upper-left). This yields two eigenvector principle 
components, describing how the aptamers tend to correlate with each other. In agreement with the observed 
block structure of the aptamer profiles, we obtain an all positive first eigenvector with major contribution of the 
aptamers TD05, TD08, and TE02 (Fig. 3d, upper right) and a second eigenvector consisting primarily of sgc8a 
(Fig. 3d, lower-right). These eigenvectors are strongly anticorrelated, indicating that the aptamers cluster cleanly 
based on cell type. We use these eigenvectors to define a two-parameter coloring scheme, coloring each data point 
corresponding to a cell in the coordinate space according to its amplitudes along the two eigenvectors. Cells con-
taining mostly human transcripts have amplitudes primarily along the first eigenvector (blue, Fig. 3c upper-right), 
while cells containing mostly mouse transcripts have amplitudes primarily along the second eigenvector (purple, 
Fig. 3d, lower-right). These results demonstrate that transcriptional signatures cluster with known patterns of 
aptamer binding and, more broadly, that aptamers can be used to label specific cell types in a format that can be 
read out with mRNA sequencing data.
Discussion
While single cell mRNA profiling provides a valuable snapshot into the inner workings of cells, it is just one of 
many characterizations of the cellular space. Inaccessible from transcriptome data, the proteome contains traces 
of post-translational regulatory events and exhibits different temporal dynamics57,58. Tapping into both domains, 
Apt-seq provides a strategy for highly multiplexed, single cell surface profiling simultaneous with the transcrip-
tome. Because Apt-seq uses polyadenylated aptamer probes, it is compatible with most common single cell tran-
scriptome sequencing methods, including Drop-seq, InDrops, and their commercial variants.
Apt-seq mirrors Abseq, and its successors cellular indexing of transcriptomes and epitopes by sequencing 
(CITE-seq) and RNA expression and protein sequencing (REAP-seq), in that it allows combined surface and 
transcriptome profiling of tens-of-thousands of single cells at high throughput26–28. However, aptamers provide 
practical and functional advantages over antibodies. In practical terms, aptamers are faster and cheaper to gen-
erate against many novel targets than antibodies. The in vitro SELEX process can be performed directly on living 
cells, obviating the need for antigen purification, which is not possible for many targets. Thus, Abseq may be 
preferred when the marker is best detected by a readily-available antibody, while Apt-seq may be superior for 
novel targets. Additionally, while antibodies require tag conjugation, aptamers can be used directly, since they 
are already sequenceable nucleic acids. In addition, patents on the original SELEX method have expired and 
new protocols have emerged that should expand the library of high-quality, specific aptamers37,59–61. Moreover, 
aptamers can be synthesized with higher purity and reliability than antibodies through established chemical syn-
thesis pipelines; this may allow aptamers to overcome the poor reproducibility that has plagued antibodies, and 
potentially achieve higher experimental reliability.
Apt-seq provides new capabilities for high throughput single cell characterization. In addition to scaling num-
bers of cells sequenced per sample, there is an increasing interest in scaling the number of samples sequenced 
in total. Ideally, many samples would be pooled and sequenced on a single run, but the need to index each one 
necessitates microfluidic barcoding of every sample, an expensive and labor-intensive process. Apt-seq can 
address this by labeling samples with unique surface aptamers that can be used independent of transcriptome 
Figure 3. Mixed human-mouse two cell type experiment. (a) The number of unique aptamer reads per cell 
is drawn on the left. On the opposite side, all unique mRNA reads are displayed. The cells are ordered from 
bottom to top according to the number of assigned human mRNA reads divided by the total number of assigned 
mRNAs in decreasing order. (b) Two-dimensional histogram of counts per aptamer and cell. The order of the 
cells is the same as in (a). (c) Two-dimensional histogram of the transcript counts for the 200 most variable 
transcript equivalence classes. The maximum read number is truncated at 100. The order of the cells is the 
same as in (a,b). (d) Barnyard plot of the two cell transcriptome data. The first two principal components of the 
cell versus aptamer read matrix are superimposed in color space. Color code is given in the insert. The relative 
contribution of each aptamer to the first two principal components is given.
www.nature.com/scientificreports/
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data to batch samples together in one microfluidic barcoding run. Since after cell washing the free aptamer con-
centration is orders of magnitude below their dissociation constant, there should be minimal cross contamination 
between samples.
Aptamers and antibodies can bind internal epitopes of cells using fixation and permeabilization protocols; 
however, such binding may be better with the smaller aptamers, having a hydrodynamic diameter of ~2 nm com-
pared to ~15 nm for antibodies41,62. Indeed, many aptamers are readily internalized and staining of intracellular 
compartments can be more effective than with antibodies63–65. This will be important for combining intracellular 
proteomic and transcriptomic readouts66. Aptamers also enable measurement opportunities not possible with 
antibodies. For example, a raw aptamer library produced by cell-SELEX can be directly applied to cells, allowing 
different cell types to be inferred based on aptamer spectrum, rather than assembling an aptamer library from 
known binders. This should allow differentiation between cells even when distinct biomarkers are not known a 
priori. Additionally, multidentate, bispecific, or multipiece aptamers can be constructed by combining binding 
sequences in the same aptamer67,68, allowing assessment of epitope proximity in a way currently accomplished 
with fluorescence or proximity ligation assays, but in a format that can be highly multiplexed and performed 
simultaneously with cell surface and transcriptome profiling. Furthermore, riboswitch-like aptamers have a 
unique ability to bind small molecules and, thus, Apt-seq opens new possibilities for adding cellular metabolite 
characterization to simultaneous protein and nucleic acid measurements in single cells69.
Methods
Aptamer structure prediction. The aptamer structure was predicted by the RNAstructure web-server 
(https://rna.urmc.rochester.edu/RNAstructureWeb/) with default parameters55.
Cell cultures. Ramos and 3T3 cells were cultured at 37 °C in RPMI-1640 medium supplemented with antibi-
otics and 5% fetal bovine serum (FBS) in the presence of 5% CO2.
Aptamer staining. Aptamers (from IDT) were folded as described before50. Briefly, they were diluted to 
0.5 μM in aptamer folding buffer (F) (1× PBS, 5 mM MgCl2, 4.5 gl−1 glucose) and heated to 95 °C for five min-
utes then cooled on ice for 10 min. The folded aptamers were pooled at a concentration of 62.5 nM each as stock 
solution.
3T3 and Ramos cells were resuspended in aptamer binding buffer (B) (buffer F supplemented with 1 mg/ml 
BSA and 0.1 mg/ml salmon sperm DNA). For the qPCR experiments either 3T3 or Ramos cells were diluted to 
about 6 × 105 cells/ml and incubated with 31.25 nM of each aptamer. Cells were washed five times by centrifuga-
tion and resuspension cycles. For the single cell experiment 106 Ramos cells where mixed with 3*105 3T3 cells and 
31.25 nM of each aptamer in 1 ml buffer B. The cell suspension was incubated for 30 min on ice and washed in ice 
cold buffer B for five centrifugation and resuspension cycles.
Quantitative PCR. For each qPCR replicate either a suspension of about 4200 aptamer-stained cells or, 
in controls, the corresponding volume of supernatant was loaded. Aptamer specific primers (from IDT) were 
used to amplify individual sequences (Supplementary Table 2). Signal was detected on a QuantStudio5 (Applied 
Biosystems) qPCR machine with SYBR green as reporter. A control experiment was performed to assess back-
ground priming on non-target aptamers and was found to be below detection limit. Amplification standard 
curves were measured for all aptamer primer pairs in triplicate. The model C(n) = C0bn, where C(n) corresponds 
to the concentration after n PCR cycles and C0 to the start concentration, was log transformed and fit by linear 
regression to obtain the amplification rate b and the detection concentration C(nCt), which is reached at the cycle 
threshold (Ct). Both calculated constants were used to estimate the aptamer concentration in the experiment. 
Uncertainty in the constants was propagated and final uncertainty of the concentration estimates is presented as 
one sample standard deviation with applied Bessel’s correction.
Single cell experiment. The aptamer-stained cell suspension was diluted in ice cold PBS containing 0.1% 
BSA to a final concentration of 1.06*105 cells/ml.
Single cell experiments were performed as described by13 (online protocol:70) with the following modi-
fications. About 2000 beads were used for further processing, corresponding to about 100–200 cells. After 
reverse transcription with Maxima H Minus Reverse Transcriptase (Thermo Fisher), which produces barcoded 
cDNA-mRNA hybrids and barcoded double-stranded aptamers, we amplified both libraries together by 13 cycles 
of PCR. DropSeq uses template switching to introduce the sequence ACTCTGCGTTGATACCACTGCTT at 
the 3′-end of the cDNA which allows use of a single primer (smart PCR) (Supplementary Table 2) to amplify 
the complete barcoded construct. Since template switching is much more efficient on 5′-capped mRNA, it only 
rarely happens on aptamers. Therefore, we use a specific reverse primer for each different aptamer flanking region 
(Supplementary Table 1), which we add to the PCR mix at a ratio of 1:20 compared to the smart PCR primer. Next 
DropSeq uses tagmentation (Nextera) to trim the transcripts to a mean length of about 500 bp and to introduce 
the sequence overhang GTCTCGTGGGCTCGG. Since the length of the aptamers is significantly shorter, tag-
mentation is not expected to act on them. To enable downstream joint processing of aptamers and transcripts we 
introduced the tagmentation overhang as part of the aforementioned specific primers. We processed the sample 
further as described13. The cDNA library was sequenced on a MiSeq device (Illumina) with a MiSeq Reagent Kit 
v3 (Illumina) in paired-end mode.
Sequencing and data analysis. The python scripts for the evaluation of InDrops experiments71 was 
adjusted to be applicable to the barcoding scheme of the DropSeq experiment. Without attempting any error 
correction, in a first pass all cellular barcodes with a count above 2000 where retained, which yielded 210 distinct 
barcodes. The corresponding sequences, containing transcripts and aptamers, were evaluated with Kallisto in the 
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UMI-aware mode to generate a pseudo-alignment and to map transcripts to equivalence classes72,73. To reduce the 
influence of stochastic fluctuations in the data, cells were only included for further analysis if they yielded a min-
imum of 4500 unique transcript reads; 58 cells passed this filter. For display purpose, the 200 equivalence classes 
with the highest variance were selected (Fig. 3c). A barnyard plot was generated based on equivalence classes that 
could be unambiguously assigned to either mouse or human only (Fig. 3d). Aptamer sequences were identified 
separately by the program cutadabt74. For each aptamer three overlapping 20mers were generated and each of 
these fragments was used as a cutadabt query and tested against all sequences. If a sequence contained a consec-
utive 20mer that matched the query with at most one base mismatch, the sequence was considered a read of that 
aptamer. The identified aptamer sequences were collapsed based on their UMI. SVD was calculated based on the 
mean-centered normalized cells versus aptamers count matrix. The color of the x-coordinate in the barnyard plot 
corresponds to the amplitude of the first eigenvector (cyan) and the y-coordinate to the inverse amplitude of the 
second eigenvector (magenta) (Fig. 3d).
Data availability. The data that support the findings of this study are available from the corresponding 
author upon reasonable request.
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